The Gaping Hole in Medical Education on Cannabis
Sarah Mann, MD analyses the knowledge gap in medical schools on cannabis therapeutics and how education can empower both healthcare professionals and the patients that they serve.
Archive for month: February, 2021
The Case for Cannabis: Cannabis, Testosterone, and Gender Inequality
SCC member Kenzi Riboulet-Zemouli identifies a coherent nomenclature for cannabis products (whether derived from Cannabis sativa L. or not). The paper was published in Drug Science, Policy and Law in December of 2020.
Apply to be on the SCC Board of Directors
PREAMBLE The Society of Cannabis Clinicians (SCC) has been in the forefront of cannabinoid medicine practice and education for more than 20 years. It is one of the premier organizations advocating for expanding clinical research and increasing the evidence-based application of medicinal cannabis. It is a 501(c)3 non-profit renowned for its quarterly presentations by individuals…
Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis
SCC member Kenzi Riboulet-Zemouli identifies a coherent nomenclature for cannabis products (whether derived from Cannabis sativa L. or not). The paper was published in Drug Science, Policy and Law in December of 2020.
Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study
SCC member Kenzi Riboulet-Zemouli identifies a coherent nomenclature for cannabis products (whether derived from Cannabis sativa L. or not). The paper was published in Drug Science, Policy and Law in December of 2020.
Effects of cannabis use on alcohol consumption in a sample of treatment-engaged heavy drinkers in Colorado
SCC member Kenzi Riboulet-Zemouli identifies a coherent nomenclature for cannabis products (whether derived from Cannabis sativa L. or not). The paper was published in Drug Science, Policy and Law in December of 2020.
Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study
SCC member Kenzi Riboulet-Zemouli identifies a coherent nomenclature for cannabis products (whether derived from Cannabis sativa L. or not). The paper was published in Drug Science, Policy and Law in December of 2020.
Job Opportunity: PlantMed Medicinal Cannabis Clinic
PlantMed is looking for open minded, compassionate and understanding doctors to join their team.
Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
Authors Alessia Furgiuele, Marco Cosentino, Marco Ferrari & Franca Marino Published in Journal of Neuroimmune Pharmacology January 2021 Abstract Multiple sclerosis (MS) is the most common chronic autoimmune disease of the central nervous system. Efficacy of treatments for MS is associated with risk of adverse effects, and effective and well-tolerated drugs remain a major unmet…
The antimicrobial potential of cannabidiol
Authors Mark A. T. Blaskovich, Angela M. Kavanagh, Alysha G. Elliott, Bing Zhang, Soumya Ramu, Maite Amado, Gabrielle J. Lowe, Alexandra O. Hinton, Do Minh Thu Pham, Johannes Zuegg, Neil Beare, Diana Quach, Marc D. Sharp, Joe Pogliano, Ashleigh P. Rogers, Dena Lyras, Lendl Tan, Nicholas P. West, David W. Crawford, Marnie L. Peterson, Matthew…